Sharon Worcester is an award-winning medical journalist for MDedge News. She has been with the company since 1996, first as the Southeast Bureau Chief (1996-2009) when the company was known as International Medical News Group, then as a freelance writer (2010-2015) before returning as a reporter in 2015. She previously worked as a daily newspaper reporter covering health and local government. Sharon currently reports primarily on oncology and hematology. She has a BA from Eckerd College and an MA in Mass Communication/Print Journalism from the University of Florida. Connect with her via LinkedIn and follow her on twitter @SW_MedReporter.
News

APHINITY 6-year data: Benefit ongoing in HER2+ early BC, no significant OS benefit
- Author:
- Sharon Worcester
Publish date: December 12, 2019
News

Oral arginine emerges as potential adjuvant for vaso-occlusive crisis management
- Author:
- Sharon Worcester
Publish date: December 9, 2019
News

Aspirin plus a DOAC may do more harm than good in some
- Author:
- Sharon Worcester
Publish date: December 8, 2019
News

Certolizumab may reduce uveitis flares, axSpA disease activity
- Author:
- Sharon Worcester
Publish date: December 6, 2019
News

TULIP trials show clinical benefit of anifrolumab for SLE
- Author:
- Sharon Worcester
Publish date: December 5, 2019
News

Upadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitis
- Author:
- Sharon Worcester
Publish date: December 3, 2019
News

ASH preview: Key themes include tackling CAR T obstacles, sickle cell advances, VTE
- Author:
- Sharon Worcester
Publish date: November 26, 2019
News

Large population-based study underscores link between gout, CVD event risk
- Author:
- Sharon Worcester
Publish date: November 23, 2019
News

SPIRIT-H2H results confirm superiority of ixekizumab over adalimumab for PsA
- Author:
- Sharon Worcester
Publish date: November 21, 2019
News

COAST-X top-line results: Ixekizumab improves nonradiographic axSpA vs. placebo
- Author:
- Sharon Worcester
Publish date: November 21, 2019
News

Biologic DMARDs appear as effective in elderly-onset RA as in young-onset RA
- Author:
- Sharon Worcester
Publish date: November 18, 2019
News

Weekly tocilizumab provides durable benefits for giant cell arteritis patients
- Author:
- Sharon Worcester
Publish date: November 13, 2019
News

B-cell-poor RA responds better to tocilizumab than to rituximab
- Author:
- Sharon Worcester
Publish date: November 12, 2019
News

Guselkumab improves psoriatic arthritis regardless of prior TNFi use
- Author:
- Sharon Worcester
Publish date: November 11, 2019
News
A progressive exercise intervention improved AGFR in breast cancer survivors
- Author:
- Sharon Worcester
Publish date: November 8, 2019